Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tetraphase Pharmaceuticals Inc Announces Pricing of Public Offering of Common Stock

Thursday, 7 Nov 2013 09:09am EST 

Tetraphase Pharmaceuticals Inc announced the pricing of an underwritten public offering of 4.5 million shares of its common stock at a price of $10.00 per share, less underwriting discounts and commissions. The size of the offering was upsized from 3.3 million shares to 4.5 million shares, raising aggregate gross proceeds of $45 million. Tetraphase has granted the underwriters a 30-day option to purchase 675,000 additional shares of common stock on the same terms and conditions. The offering is expected to close on or about November 13, 2013, subject to customary closing conditions. BMO Capital Markets and Stifel are acting as joint book-running managers. Guggenheim Securities, JMP Securities, and Needham & Company are acting as co-managers. 

Company Quote

1.09 +2.91%
22 Dec 2014